353 related articles for article (PubMed ID: 26739048)
1. Leukocyte Immunoglobulin-Like Receptor 1-Expressing Human Natural Killer Cell Subsets Differentially Recognize Isolates of Human Cytomegalovirus through the Viral Major Histocompatibility Complex Class I Homolog UL18.
Chen KC; Stanton RJ; Banat JJ; Wills MR
J Virol; 2016 Jan; 90(6):3123-37. PubMed ID: 26739048
[TBL] [Abstract][Full Text] [Related]
2. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.
Gumá M; Budt M; Sáez A; Brckalo T; Hengel H; Angulo A; López-Botet M
Blood; 2006 May; 107(9):3624-31. PubMed ID: 16384928
[TBL] [Abstract][Full Text] [Related]
3. The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells.
Prod'homme V; Griffin C; Aicheler RJ; Wang EC; McSharry BP; Rickards CR; Stanton RJ; Borysiewicz LK; López-Botet M; Wilkinson GW; Tomasec P
J Immunol; 2007 Apr; 178(7):4473-81. PubMed ID: 17372005
[TBL] [Abstract][Full Text] [Related]
4. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.
Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M
J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055
[TBL] [Abstract][Full Text] [Related]
5. Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts.
Cerboni C; Mousavi-Jazi M; Linde A; Söderström K; Brytting M; Wahren B; Kärre K; Carbone E
J Immunol; 2000 May; 164(9):4775-82. PubMed ID: 10779784
[TBL] [Abstract][Full Text] [Related]
6. The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack.
Dassa L; Seidel E; Oiknine-Djian E; Yamin R; Wolf DG; Le-Trilling VTK; Mandelboim O
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950412
[TBL] [Abstract][Full Text] [Related]
7. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.
Béziat V; Dalgard O; Asselah T; Halfon P; Bedossa P; Boudifa A; Hervier B; Theodorou I; Martinot M; Debré P; Björkström NK; Malmberg KJ; Marcellin P; Vieillard V
Eur J Immunol; 2012 Feb; 42(2):447-57. PubMed ID: 22105371
[TBL] [Abstract][Full Text] [Related]
8. Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18.
Odeberg J; Cerboni C; Browne H; Kärre K; Möller E; Carbone E; Söderberg-Nauclér C
Scand J Immunol; 2002 Feb; 55(2):149-61. PubMed ID: 11896931
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j.
Cerboni C; Achour A; Wärnmark A; Mousavi-Jazi M; Sandalova T; Hsu ML; Cosman D; Kärre K; Carbone E
Eur J Immunol; 2006 Mar; 36(3):732-41. PubMed ID: 16479538
[TBL] [Abstract][Full Text] [Related]
10. Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ.
Galitska G; Coscia A; Forni D; Steinbrueck L; De Meo S; Biolatti M; De Andrea M; Cagliani R; Leone A; Bertino E; Schulz T; Santoni A; Landolfo S; Sironi M; Cerboni C; Dell'Oste V
Front Immunol; 2021; 12():532484. PubMed ID: 33897679
[TBL] [Abstract][Full Text] [Related]
11. Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets.
Muntasell A; Pupuleku A; Cisneros E; Vera A; Moraru M; Vilches C; López-Botet M
J Immunol; 2016 May; 196(9):3818-27. PubMed ID: 26994220
[TBL] [Abstract][Full Text] [Related]
12. Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2.
Valés-Gómez M; Shiroishi M; Maenaka K; Reyburn HT
J Virol; 2005 Feb; 79(4):2251-60. PubMed ID: 15681427
[TBL] [Abstract][Full Text] [Related]
13. Late Development of FcεRγ
Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
Front Immunol; 2018; 9():1050. PubMed ID: 29868012
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus-Infected Primary Endothelial Cells Trigger NKG2C+ Natural Killer Cells.
Djaoud Z; Riou R; Gavlovsky PJ; Mehlal S; Bressollette C; Gérard N; Gagne K; Charreau B; Retière C
J Innate Immun; 2016; 8(4):374-85. PubMed ID: 27116381
[TBL] [Abstract][Full Text] [Related]
15. Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells.
Hammer Q; Rückert T; Borst EM; Dunst J; Haubner A; Durek P; Heinrich F; Gasparoni G; Babic M; Tomic A; Pietra G; Nienen M; Blau IW; Hofmann J; Na IK; Prinz I; Koenecke C; Hemmati P; Babel N; Arnold R; Walter J; Thurley K; Mashreghi MF; Messerle M; Romagnani C
Nat Immunol; 2018 May; 19(5):453-463. PubMed ID: 29632329
[TBL] [Abstract][Full Text] [Related]
16. NK cell receptors involved in the response to human cytomegalovirus infection.
Gumá M; Angulo A; López-Botet M
Curr Top Microbiol Immunol; 2006; 298():207-23. PubMed ID: 16323417
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection.
Wagner CS; Riise GC; Bergström T; Kärre K; Carbone E; Berg L
J Immunol; 2007 Mar; 178(6):3536-43. PubMed ID: 17339449
[TBL] [Abstract][Full Text] [Related]
18. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes.
Costa-García M; Ataya M; Moraru M; Vilches C; López-Botet M; Muntasell A
Front Immunol; 2019; 10():687. PubMed ID: 31001281
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses.
Wu Z; Sinzger C; Reichel JJ; Just M; Mertens T
J Virol; 2015 Mar; 89(5):2906-17. PubMed ID: 25540381
[TBL] [Abstract][Full Text] [Related]
20. Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection.
Peppa D; Pedroza-Pacheco I; Pellegrino P; Williams I; Maini MK; Borrow P
Front Immunol; 2018; 9():474. PubMed ID: 29616021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
